Monitor for any future conversion to a Schedule 13D, which would signal activist intent. No change in position suggests continued passive holding.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 4 $5.88entry
- T+1 · 12d ago −8.16%α −3.75% · $5.40
- T+5 · 6d ago −2.04%α −1.13% · $5.76
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Millennium Management LLC and related entities filed an amended Schedule 13G disclosing a 5.6% passive stake in Cytek Biosciences as of September 30, 2026, down from a prior 5.6% stake. The filing is a routine update with no material change in ownership.
Key Financial Metrics
Key Facts
- Millennium Management LLC reported beneficial ownership of 7,281,488 shares of Cytek Biosciences common stock, representing 5.6% of shares outstanding as of September 30, 2026.
- Integrated Core Strategies (US) LLC reported 5,870,954 shares, or 4.5%.
- The filing is an amendment to a Schedule 13G, indicating passive investment intent under Rule 13d-1(c).
- The prior 13G/A filed on August 6, 2026 also showed Millennium at 5.6% and Integrated Core at 4.5%, indicating no change in reported positions.
Financial Impact
No change in reported stake; passive position of 5.6% of shares outstanding.
Risk Factors
- Passive stake filing; no indication of activist intent or material change in ownership.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001104659-26-122222 |
| Document: 0001104659-26-122222-index-headers.html | 0001104659-26-122222 |
| Document: 0001104659-26-122222-index.html | 0001104659-26-122222 |
| Document: 0001104659-26-122222.txt | 0001104659-26-122222 |
Track record
14 reports on CTKB
1 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +1.49% at T+1 after the Jun 11, 2026 report. 1 of 3 went positive at some point.
Filters
- Nov 16, 20261d ago ITC Section 337 Neutral 3/10 Entry $5.78 Now $5.63 −2.60% settles Nov 18
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $5.84 to $5.63 Now $5.63 −3.60% ▼ −3.60% −1.68% vs SPY
- Nov 10, 20266d ago Institutional Cluster Bullish 4/10 Entry $5.79 to $5.76 Now $5.63 −2.76% ▼ −0.52% −1.84% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $5.40 to $5.83 Now $5.63 +4.26% ▲ +7.96% +7.65% vs SPY
- Nov 3, 202613d ago SC 13G/A Neutral 2/10 Viewing Entry $5.88 to $5.40 Now $5.63 −4.25% ▼ −8.16% −3.75% vs SPY
- Oct 21, 202626d ago Press Release Neutral 1/10 Entry $5.43 to $5.59 Now $5.63 +3.68% ▲ +2.95% +3.47% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $5.71 to $5.68 Now $5.63 −1.40% ▼ −0.53% +0.19% vs SPY
- Aug 24, 202612w ago 8-K Bearish 7/10 Entry $4.44 to $4.58 Now $5.63 −26.80% ▼ −3.15% −2.83% vs SPY
- Jun 25, 202620w ago 8-K Neutral 2/10 Entry $4.48 to $4.34 Now $5.63 +25.67% ▼ −3.13% −4.77% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers